ARCS Australia
Cognitio
Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting
Be sure to visit the podcast's website and support the creator: www.arcs.com.au
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Taking Control of Your Own Development, with Rod Matthews 02.11.2026 21:32
When you think of professional development, what comes to mind? Training courses, conferences, a promotion, a certificate on the wall? Rod Matthews argues that if development is something we attend, we’ve handed control of it to someone else. In this episode of Cognitio, host Tim Boyle shares highlights from LifeSciences Australia’s webinar Taking Control of Your Own Development. Rod reframes prof...
Behind the Scenes: Running a Global Pharmacovigilance System 26.10.2026 21:43
What does it actually take to keep a global pharmacovigilance system running across 20+ countries? In this episode of Cognitio, host Tim Boyle is joined by Erica Bell, Project Lead and Deputy QPPV at Commercial Eyes. Erica takes us inside her work leading a global patient safety team for a client headquartered in Asia, while also acting as the local affiliate for Australia, New Zealand and Canada....
What AI Can’t Do (Yet): An Honest Gap Analysis for Regulatory Professionals 19.10.2026 20:41
Your team is already using AI. The real question is what it can be trusted to do. In this episode of Cognitio, regulatory affairs specialist Chris Ozga, co-founder of Trial Edge AI, gives a candid look at where today’s AI tools fall short in regulatory work for medical devices, IVDs and software as a medical device. He’s clear from the outset that this is not an anti-AI talk. It’s a practical guid...
Enabling Leadership with Zak Huang 12.10.2026 49:41
What if leadership is measured not by what you achieve, but by what becomes possible because of you? Physician and global regulatory leader Zak Huang shares his enabling leadership framework: elevate the thinking, remove the obstacles, build the capability. Drawing on a real BLA filing where a 200-person company mapped 160 issues and filed three months after phase three data, Zak shows how the fra...
Making Safety Part of Drug Design 28.09.2026 46:19
Why does fewer than one in ten drugs that enter clinical trials ever reach patients — and what can be done about it before a compound ever gets there? In this episode of Cognitio, Richard Knight, toxicologist and co-founder of Apconix, a nonclinical consultancy and lab working with biotech and pharma companies worldwide. Richard spent twenty years in global safety assessment at AstraZeneca, includ...
Navigating Complexity: Multi-Site Governance and AI in Research Oversight 21.09.2026 25:47
Ethics approval is only the first hurdle for a clinical trial. Every site then needs its own research governance review, and that can cost patients precious time. In this Clinical Trials Day webinar, Angela Scheppokat, Manager Governance at the Royal Melbourne Hospital Office for Research, explains how Melbourne Health, Peter MacCallum Cancer Centre and the Royal Women's Hospital built a mutua...
Between Leadership and Dependence: Australia's HTA System Under Pressure 07.09.2026 31:04
Australia occupies an unusual position in global pharmaceuticals. It is regarded as a leader in cost effectiveness assessment, and at the same time it depends on innovation funded largely elsewhere. What does that dual role mean for patient access and for the medicines that reach this market? In this episode of Cognitio, Tim Boyle presents a LifeSciences Australia Market Access Special Interest Gr...
What the Coroners Know 24.08.2026 34:34
Every year in England and Wales, coroners write around 450 reports naming actions that could prevent future deaths. Roughly one in five involves a medicine. They are public, they are searchable, and according to our guest, essentially no pharmaceutical company is using them for pharmacovigilance. Dr Georgia Richards is an epidemiologist at King's College London and the founder of the Preventab...
Draw It Before You Say It 17.08.2026 33:59
Our sector speaks in technical language, and that language is precise, accurate and often impenetrable to the people it is meant to serve. In this episode of Cognitio, Tim Boyle hands the microphone to Jessamy Gee, founder and director of Think in Colour and Australia's first IFVP certified master visual practitioner. Jessamy works as a graphic recorder, translating complex discussion into a v...
How Do We Know It Isn't Just Luck? Biostatistics in Early Phase Trials 10.08.2026 29:52
Every early phase trial ends with a number, and with a judgement about whether that number means anything. In this episode of Cognitio, Professor Rory Wolfe of the Monash University Clinical Trial Centre and medical statistician Dr Alan Herschtal set out how biostatistics underpins that judgement, and why it belongs at the first planning meeting rather than the last. They cover why clinical develo...
Invisible, Essential and Overloaded: Rethinking Medical Operations 03.08.2026 30:10
Medical operations teams are often essential to the work of medical affairs, yet much of their contribution remains unseen. At the same time, growing workloads, limited resources and constant interruptions can leave teams operating in a cycle of reactive support. In this episode of Cognitio, webinar convener Lee-Mai Pang speaks with Sanofi medical operations leader Menai Johnson about breaking tha...
Adoption of AI in Pharmacovigilance 27.07.2026 31:29
Artificial intelligence is moving from experimentation into practical use across pharmacovigilance, but adoption brings important questions about accuracy, privacy, validation and accountability. In this episode of Cognitio, Ata Arkham, Senior Patient Safety Specialist at AstraZeneca, joins webinar moderator Matt Iglesias to explore how AI is being used across global and local pharmacovigilance op...
Bringing Clinical Trials Closer to Home: Building a Regional Trial Service 20.07.2026 29:40
Clinical trials can offer patients access to new treatments, but geography remains a major barrier for people living in rural, regional and remote communities. In this episode of Cognitio, Tim Boyle is joined by Katrina Orr and Nadine Herren from the WA Country Health Service Trial Centre. They share how their team has developed a statewide clinical trial service model designed to bring trial oppo...
From Discovery to Patient Impact: Perseverance, Integrity and the Path to Innovation 15.07.2026 13:59
In this episode of Cognitio, the podcast of LifeSciences Australia , we revisit a conversation recorded at the 2025 Annual Conference with Associate Professor Pegah Varamini from the University of Sydney. A clinical pharmacist and cancer researcher, Pegah shares the personal and professional experiences that led her to focus on developing targeted therapies for difficult-to-treat cancers, includin...
Paul Batten, ObjectivoData 25.05.2026 21:10
In this BioBeacon edition of the Cognitio Podcast, ARCS CEO Tim Boyle speaks with Paul Batten, founder of ObjectivoData, about his unexpected journey from mechanical engineering and McLaren to clinical trial technology. Paul shares how working on a COVID-era telehealth trial exposed the need for more intuitive, flexible and user-centred clinical trial systems. That experience became the foundation...
Dr Daniel Beard, Founder and CSO ShearFlow 12.05.2026 26:39
What if you could give a stroke patient more time? That is the question driving Dr Daniel Beard and the team at ShearFlow, a biotech spin-out from the University of Newcastle developed in joint venture with Harvard University. In this episode, ARCS intern Iqra sits down with Daniel to trace a career that has taken him from a fascination with the brain's blood vessels, through a PhD in stroke r...
AI Basics for Regulatory Professionals: Safe Use, Smart Prompting and Human Accountability 04.05.2026 38:52
Artificial intelligence is already reshaping how regulatory professionals work—but with opportunity comes responsibility. In this episode of Cognitio, we bring you key insights from an ARCS webinar led by Kyle from GXP Vigilance, exploring how AI is being used across regulatory affairs, pharmacovigilance and quality environments, and what professionals need to understand to use it safely and effec...
ARCS Weekly Wrap - 1 May 2026 01.05.2026 1:31
This week on Top 3 with Tim, ARCS CEO Dr Tim Boyle shares the biggest updates shaping the ARCS community and Australia’s life sciences sector. In this short update: • Final call for 2026 ARCS Annual Conference early bird registrations • ARCS announces its new partnership with the Australian Institute of Company Directors (AICD) and the upcoming LifeSciences Company Directors Course • Highlights fr...
Signals to Clinical Evidence 29.04.2026 29:03
How do we separate misinformation from meaningful public health signals, and what happens when digital intelligence is combined with clinical evidence? In this episode of Cognitio, we explore how online sentiment, AI-powered surveillance and real-world healthcare data can work together to identify, investigate and validate emerging vaccine safety concerns. Dr Gerardo Luis Dimaguila, Informatics Le...
S02E10 High Performance, Hidden Challenges 20.04.2026 43:32
What does high performance really look like when it’s shaped by lived experience? In this episode of Cognitio , we explore the intersection between professional capability and chronic illness—and how navigating personal health challenges can fundamentally shape resilience, leadership, and perspective in the life sciences sector. Hosted by Anna Megalakakis from ARCS, this conversation brings togeth...
Teams First: Cultivating Resilient Leaders in Competitive Environments 13.04.2026 39:09
What can elite sport teach us about leadership in the workplace? In this episode of the Cognitio Podcast, Tim Boyle sits down with Tomek Szklarski, Head Coach of the Australian National Handball Team, to explore how high-performance sporting environments develop resilient leaders, build trust under pressure, and create cultures where teams thrive. Drawing on his experience as both a professional a...
Designing with, not for: The Power of Patient Co-Creation 31.03.2026 30:26
What does it really mean to design healthcare with patients? In this episode of the Cognitio Podcast, Georghien Wiley, ARCS Convener for the Patient Engagement Interest Area, leads a powerful and deeply personal discussion on patient co-creation. Through real-world experiences, this episode explores the realities of navigating the healthcare system in Australia, particularly for patients and carer...
Reimbursement Pathways and Patient Access for Cell and Gene Therapies in Australia 23.03.2026 39:59
Cell and gene therapies such as CAR-T are transforming modern medicine, offering new treatment options for cancers and rare diseases. But getting these breakthrough therapies to patients is not straightforward. In this episode of the Cognitio Podcast, Warwick Shaw from Johnson & Johnson explores how advanced therapies move from regulatory approval to reimbursement in Australia. The discussion...
ARCS Weekly Wrap 20 March 2026 20.03.2026 2:35
Three signals this week point to a sector at a turning point. Australia’s life sciences industry is accelerating—with stronger local capability, growing global engagement, and a more coordinated national R&D strategy taking shape. But there’s a critical question we need to address. As we move toward a more economically driven innovation model, how do we ensure health and medical research remai...
Regulatory Guidelines Supporting Non-Animal Models in Pharmaceutical Development 16.03.2026 36:09
In this episode of Cognitio , Tim Boyle speaks with Dr Natalie Anderson about the evolving regulatory landscape for non-animal models in pharmaceutical development. We explore global reforms at the US FDA and European Medicines Agency, the application of the Three Rs, and how Australia’s TGA is responding to advances in organoids, organ-on-chip technologies and in silico modelling. The discussion...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.